FDA approves Ozempic to help reduce risk of worsening chronic kidney disease
The FDA’s approval of Ozempic to battle chronic kidney disease “allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of ...
The American Journal of Managed Care1h
Case Series Shows Possible Link Between Semaglutide, Ophthalmic Complications
Results from a case series identified a potential association between ophthalmic complications and the rapid correction of hyperglycemia, brought on by patients using either semaglutide or tirzepatide ...
Hosted on MSN7h
Ozempic receives FDA nod for treating chronic kidney disease; experts explain how diabetes drug reduces CKD risk
The US Food and Drug Administration (FDA) approval is based on the clinical trials that showed how Ozempic, the diabetes drug ...
BBC Good Food on MSN8h
Weight loss drugs – are they right for you?
Find out all you need to know about Ozempic and other weight loss drugs, including the dangers and side effects ...
Clarksville Now23h
What are weight loss injections, and can they work for me? | Ask the Expert
Whether you’re looking to shed pounds or enhance your physique, Bella Medical Spa has the tools to support your journey, and ...
An Ozempic Expert Explains What You Need to Know Before Taking GLP-1 Drugs
Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...
The Marshall News Messenger1d
To Your Good Health: Older couple won't tone down the intensity of their exercise
My parents are both retired medical professionals who are in their early 70s. My father has diabetes that he manages with ...
FiercePharma1d
Hims & Hers tackles pharma industry drug pricing in Super Bowl ad for compounded GLP-1s
Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...
Hims & Hers: Potential Risks Ahead, But Shorting May Be Premature
Hims & Hers may leverage FDA compounding exemptions to further extend its compounded GLP-1 offerings. Learn why HIMS stock is ...
Opinion
Sun Journal1dOpinion
Older couple won’t tone down the intensity of their exercise
My parents are both retired medical professionals who are in their early 70s. My father has diabetes that he manages with medication, and he also has a history of recurrent prostate cancer. My mother ...
Dr. Roach: Older couple won’t tone down the intensity of their exercise
My parents are both retired medical professionals who are in their early 70s. My father has diabetes that he manages with ...
Managed Healthcare Executive1d
FDA Approves Ozempic to Reduce Kidney Disease in Type 2 Diabetes
Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...